title: Antenatal corticosteroids policies in 14 European countries: factors associated with multiple courses. The EURAIL survey.
abstract: OBJECTIVE
  To describe antenatal corticosteroids (ANCs) policies in European obstetric units and to determine factors that influence the use of multiple courses.
  
  
  METHODS
  641 obstetricians from obstetric departments covering a geographical area in 14 European countries responded to a questionnaire on ANCs policies. Logistic regression was used to identify factors that were related to the use of multiple ANCs courses.
  
  
  RESULTS
  The survey response rate was 76% (inter-country range 33-94%): 11% (0-50%) of the respondents started ANCs from 23 to 24 wk gestation, 82% from 24 to 28 wk (50-100%) and 7% from 28 to 36 wk (0-32%). Eighty-five percent of the units (63-100%) used multiple ANCs courses. After adjustment for country, number of infants delivered at 24-32 wk annually in the unit, NICU and maternal hypertension, maternal hypertension tended to be an explicative factor (OR 1.97; 95% CI: 0.75-5.17).
  
  
  CONCLUSIONS
  The high proportion of departments that initiated ANCs between 24 and 28 wk of gestation is consistent with the high incidence of neonatal morbidity and mortality in that age range. Multiple courses are overwhelmingly prescribed in Europe, although their risk/benefit ratio compared with a single dose is not yet known. The likelihood of using repeated courses of ANCs may be related to the presence of maternal hypertension, and this highlights the importance of closely monitoring women at risk of premature delivery.
authors.affiliation: National Health and Medical Research Institute (INSERM), Department of Epidemiology on Woman and Child Health, Paris, France. empana@vjf.inserm.fr
authors.forename: J P
authors.initials: JP
authors.lastname: Empana
authors.forename: M M
authors.initials: MM
authors.lastname: Anceschi
authors.forename: I
authors.initials: I
authors.lastname: Szabo
authors.forename: E V
authors.initials: EV
authors.lastname: Cosmi
authors.forename: G
authors.initials: G
authors.lastname: Breart
authors.forename: P
authors.initials: P
authors.lastname: Truffert
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D003430:Cross-Sectional Studies; D005060:Europe; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D016015:Logistic Models; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011795:Surveys and Questionnaires
chemical_list: D000305:Adrenal Cortex Hormones